DYNATRACT®: ADVANCING THE FUTURE OF DYNAMIC TRACTION IN OPEN ABDOMEN MANAGEMENT patricia.zorrilla@idival.org

PE104

DYNATRACT®: ADVANCING THE FUTURE OF DYNAMIC TRACTION IN OPEN ABDOMEN MANAGEMENT

6

 

 

 

 

Spain

Oral or Poster

Open abdomen (OA) remains a major surgical challenge, often associated with high morbidity rates, prolonged ICU stays, and increased healthcare costs. Current approaches like negative pressure wound therapy (NPWT) are effective in controlling contamination and fluid balance but fall short in preventing fascial retraction and enabling early primary closure. Dynatract® is a novel dynamic traction system developed to overcome these limitations by promoting progressive approximation of fascial edges while remaining compatible with NPWT.

Following successful preclinical testing in a porcine model, which demonstrated Dynatract®’s potential to reduce fascial edge distance and improve closure conditions, the development of the system has advanced through design iterations, biocompatibility assessments, and usability testing. A structured clinical translation pathway has been defined, including CE marking and a roadmap toward FDA clearance. The project has also involved early stakeholder engagement and health economics modeling.

Dynatract® has shown safety and mechanical effectiveness in preclinical settings. Iterative design improvements based on usability outcomes and regulatory feedback have refined the device toward clinical-grade performance. A clinical trial design is currently under preparation, and manufacturing partners have been engaged to scale up production for first-in-human studies.

Dynatract® is a promising innovation poised to reshape the management of open abdomen. With a clear translational pathway that integrates regulatory, clinical, and market access strategies, it represents a robust example of surgical technology development aiming to reduce complications, hospital stays, and costs in critical care surgery.